Patent No. 599779 Disclosed is an anti-fractalkine antibody or fractalkine-binding fragment thereof, wherein the antibody or fragment thereof comprises: (a) a CDR-H1 comprising the amino acid sequence NYYIH (b) a CDR-H2 comprising the amino acid sequence WIYPGDGSPKFNERFKG (c) a CDR-H3 comprising the amino acid sequence GPTDGDYFDY (d) a CDR-L1 comprising the amino acid sequence RASGNIHNFLA (e) a CDR-L2 comprising the amino acid sequence NEKTLAD (f) a CDR-L3 comprising the amino acid sequence QQFWSTPYT